These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 33631345)

  • 1. Angiotensin receptor-neprilisyn inhibitors: Are their beneficial effects mediated through diastolic or systolic function improvement?
    Oikonomou E; Tsioufis C; Tousoulis D
    Hellenic J Cardiol; 2020; 61(6):419-420. PubMed ID: 33631345
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?
    Konstam MA
    JACC Heart Fail; 2016 Oct; 4(10):823-825. PubMed ID: 27614938
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction.
    Docherty KF; McMurray JJV
    Int J Cardiol; 2019 Apr; 281():179-185. PubMed ID: 29891240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of angiotensin receptors and neprilysin inhibitors on myocardial remodeling in patients with chronic heart failure and atrial fibrillation].
    Uskach TM; Safiullina AA; Makeev MI; Saidova MA; Shariya MA; Ustyuzhanin DV; Zhirov IV; Tereshchenko SN
    Kardiologiia; 2019 Oct; 59(10S):64-72. PubMed ID: 31876463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.
    Prenner SB; Shah SJ; Yancy CW
    Curr Atheroscler Rep; 2016 Aug; 18(8):48. PubMed ID: 27324636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neprilysin Inhibitors: Filling a Gap in Heart Failure Management, Albeit Amidst Controversy and at a Significant Cost.
    Manolis AS; Manolis TA; Manolis AA; Melita H
    Am J Cardiovasc Drugs; 2019 Feb; 19(1):21-36. PubMed ID: 29926350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Hubers SA; Brown NJ
    Circulation; 2016 Jul; 134(3):e11-2. PubMed ID: 27436883
    [No Abstract]   [Full Text] [Related]  

  • 8. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
    Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel therapy option for heart failure with dual angiotensin receptor and neprilysin inhibition].
    Liu X; Hong K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Dec; 43(12):1025-7. PubMed ID: 26888834
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting the "Right" Perspective on Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.
    Verbrugge FH; Borlaug BA
    J Am Heart Assoc; 2020 Jul; 9(13):e017292. PubMed ID: 32552147
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
    Burnier M
    J Hypertens; 2017 Apr; 35(4):726-728. PubMed ID: 28248903
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Rajapakse NW; Kuruppu S; Ian Smith A
    Circulation; 2016 Jul; 134(3):e9-e10. PubMed ID: 27436888
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure.
    Kim S; Yoshiyama M; Izumi Y; Kawano H; Kimoto M; Zhan Y; Iwao H
    Circulation; 2001 Jan; 103(1):148-54. PubMed ID: 11136700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition.
    Feldman AM
    JACC Heart Fail; 2017 Nov; 5(11):851-852. PubMed ID: 29096796
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction.
    Ovchinnikov AG; Gvozdeva AD; Blankova ZN; Borisov AA; Ageev FT
    Kardiologiia; 2020 Dec; 60(11):1352. PubMed ID: 33487158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition.
    Tamura K; Kobayashi R; Haku S; Azushima K; Wakui H
    Hypertens Res; 2016 Nov; 39(11):753-755. PubMed ID: 27334065
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.